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Abstract
Background: Protein sequence can be obtained through Edman degradation, mass spectrometry,
or cDNA sequencing. High resolution X-ray crystallography can also be used to derive protein
sequence information, but faces the difficulty in distinguishing the Asp/Asn, Glu/Gln, and Val/Thr
pairs. Luffaculin 1 is a new type 1 ribosome-inactivating protein (RIP) isolated from the seeds of
Luffa acutangula. Besides rRNA N-glycosidase activity, luffaculin 1 also demonstrates activities
including inhibiting tumor cells' proliferation and inducing tumor cells' differentiation.
Results: The crystal structure of luffaculin 1 was determined at 1.4 Å resolution. Its amino-acid
sequence was derived from this high resolution structure using the following criteria: 1) high
resolution electron density; 2) comparison of electron density between two molecules that exist
in the same crystal; 3) evaluation of the chemical environment of residues to break down the
sequence assignment ambiguity in residue pairs Glu/Gln, Asp/Asn, and Val/Thr; 4) comparison with
sequences of the homologous proteins. Using the criteria 1 and 2, 66% of the residues can be
assigned. By incorporating with criterion 3, 86% of the residues were assigned, suggesting the
effectiveness of chemical environment evaluation in breaking down residue ambiguity. In total, 94%
of the luffaculin 1 sequence was assigned with high confidence using this improved X-ray sequencing
strategy. Two N-acetylglucosamine moieties, linked respectively to the residues Asn77 and Asn84,
can be identified in the structure. Residues Tyr70, Tyr110, Glu159 and Arg162 define the active
site of luffaculin 1 as an RNA N-glycosidase.
Conclusion:  X-ray sequencing method can be effective to derive sequence information of
proteins. The evaluation of the chemical environment of residues is a useful method to break down
the assignment ambiguity in Glu/Gln, Asp/Asn, and Val/Thr pairs. The sequence and the crystal
structure confirm that luffaculin 1 is a new type 1 RIP.
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Background
The amino-acid sequence is the most basic but critical
information for proteins. The primary structure of the pro-
tein can be obtained through Edman degradation, mass
spectrometry or cDNA method. These methods, especially
cDNA method, have been applied widely, but they still
have their own limitations [1]. Edman degradation is
expensive and cannot deal with cases where the N-termi-
nal amino-acid of protein is blocked. cDNA sequencing is
the most popular sequencing method nowadays, but it
cannot identify the amino-acid post translational modifi-
cations. Mass spectrometry has made dramatic advance in
the last decade in its technology [2], but still has difficul-
ties to give the full-length sequence and to distinguish the
residue pair Ile/Leu. X-ray sequencing method, based on
electron density, is another method to determine the pro-
tein sequence. Although this method has limited usage, it
is a useful addition to the sequencing methods in some
cases, e.g., where cDNA is not readily available. This
method has been used to determine the sequence of PAP-
Saci [3] and trichomaglin [4]. A major problem of this
method is the difficulty to distinguish residue pairs Asp/
Asn, Glu/Gln, and Val/Thr. Moreover, weak electron den-
sity of some residues located at the molecular surface also
gives rise to uncertainty for the X-ray sequence analysis.
Here, we demonstrate that the evaluation of the chemical
environments of these pairs can help to break down such
ambiguity and 86% (see Table 2) of the amino acids were
assigned with confidence on the basis of the electron den-
sity and the chemical environment evaluation of the resi-
dues.
The ribosome-inactivating proteins (RIPs) are RNA N-gly-
cosidases [5,6] that inactivate ribosome by cleaving a sin-
gle N-C glycosidic bond between adenine and ribose at
A4324 in the 28S eukaryotic mammalian rRNA or at
A2660 in the 23S Escherichia coli rRNA. The cleaved N-C
glycosidic bond is located in a loop containing a GAGA
sequence and highly conserved in rRNAs from bacteria,
plants and animals. The removal of one adenine from
rRNA by RIPs prevents the binding of elongation factor II
(EF-2) to the 60S subunit, resulting in the termination of
protein translation. In E. coli, the cleavage by RIP affects
the combination of EF-Tu and EF-G. Both EF-G and EF-Tu
protect bases in the universally conserved loop around
position 2660 of 23S rRNA. This loop is also the site of
action of cytotoxins that alter the structure of a region of
rRNA that interacts with EF-Tu and EF-G and thus abolish
protein synthesis. RIPs from plants can be classified into
three types based on the structure of the genes and mature
proteins [7]. Type 1 RIPs, such as trichosanthin [8], bryo-
din [9], α, β-momorcharin [10,11], luffin a and b [12] and
cucurmosin [13], have alkaline isoelectric points and
molecular weights ranging from 26 to 31 kDa. They typi-
cally contain a single polypeptide chain and have the
potent ability to inhibit protein synthesis in the cell free
system but are relatively non-toxic to the intact cells. Type
2 RIPs, such as ricin [14] and abrin [15], consist of two
chains, chain A and chain B, linked by disulfide bridges.
The A chain is homologous to type 1 RIPs and possesses
the ribosome-inactivating activity; the B chain, containing
a lectin domain, binds to galactosyl-terminated receptors
on the target cell surface, facilitating the entry of the A
chain into the cytoplasm of the cell. Thus, some, but not
all, type 2 RIPs are more potent toxin than type 1 RIPs
because type 1 RIPs have difficulty in entering into cells.
Type 3 RIP includes JIP60 [16] (jasmonate-induced pro-
tein) from maize, which consists of an N-terminal
domain similar to type 1 RIPs and an unrelated C-termi-
nal domain of unknown function. Most RIPs are glyco-
proteins, with varying amount and type of sugars.
RIPs have received wide attentions due to their potential
therapeutic applications in medicine and transgenic rea-
gents in agriculture. In medicine, they have been found to
possess various pharmacological activities including abor-
tifacient [17], antifungal [18], anti-tumor [19,20], antivi-
rus and HIV-1 integrase inhibitory activity [21,22]. Plants
transfected with RIP genes exhibit broad-spectrum resist-
ance to viral and fungal infection [23,24] in the plant
defense system.
We identified a new type 1 RIP, luffaculin 1 [25]. It is a
basic protein with a pI of 8.86 by IEF analysis and has a
molecular mass of about 28 kDa based on the mobility on
SDS-PAGE. Luffaculin 1 not only possesses rRNA N-gly-
cosidase activity as expected [26], but also inhibits prolif-
eration of tumor cells, induces apoptosis [27] and
differentiation on tumor cells [28].
Here, we report the high resolution (1.4 Å) crystal struc-
ture of luffaculin 1 and the protein sequence derived from
this crystal structure. The structural comparison with
other RIPs provides a structural basis to understand their
possible biological activity. The amino-acid sequence of
luffaculin 1 has not been determined by the traditional
cDNA method. We demonstrated that the primary struc-
ture of luffaculin 1 can be derived with a high degree of
confidence from the high-resolution electron density. The
existence of two independent luffaculin 1 molecules in
the asymmetric unit allows the cross-validation of this X-
ray sequence, further increasing the reliability of the
sequence assignment.
Results and discussion
Quality of the model
The crystals of luffaculin 1 belong to space group P1 and
diffract to 1.4 Å resolution with synchrotron X-ray radia-
tion. A high quality data set was collected to a complete-
ness of 86.7% and redundancy of 1.9, yielding an RmergeBMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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of 0.03 (Table 1). The current model of luffaculin 1, con-
taining two molecules in the asymmetric unit, was refined
to an R factor of 0.213 and Rfree of 0.232. Most residues in
the model fit the electron density quite well, except for
some residues in loop regions that do not have good qual-
ity of electron density. Residues 28, 206, 215–220 of mol-
ecule B were omitted from the final model due to lack of
the electron density. The quality of the stereochemistry of
the final protein structure was analyzed by PROCHECK
package [29]. The root mean square deviations (rmsd) of
bond length and bond angles are 0.007 Å and 1.153°,
respectively. The Ramachandran plot shows 91.3% of the
residues in the most favored region and 7.6% in the addi-
tional allowed region. Residues Asn 77 of molecules A
and B, which are linked to an N-acetylglucosamine,
respectively, lie just outside the generously allowed
region. Residue Tyr 141 of the molecule B, located in a
turn connecting α6 helix and α7 helix, and residue Asn
235 of the molecule A, located in a turn connecting α9
helix and α10 helix, lie in the generously allowed region.
Data collection and refinement statistics are summarized
in Table 1.
Structure description
Fig. 1 shows a ribbon representation of luffaculin 1. The
structure of luffaculin 1 contains two domains: a large N-
terminal domain composed of eight α-helices and eight β-
strands, and a smaller C-terminal domain consisting of
two α-helices (α9 and α10) and two β-strands (β9 and
β10). The secondary structure of luffaculin 1 is typical of
type 1 RIPs: six β-strands of N-terminal domain (β1, β4,
β5, β6, β7 and β8) form a mixed β-sheet. Eight helices of
N-terminal have canonical geometry [30] and enclose the
active site cleft. Helices α1 and α3 are part of the crossover
connections between the parallel strands of the β-sheet.
Helices α7 and α8 are contiguous in sequence and a single
residue (Phe 163) assumes a non-helical dihedral confor-
mation, introducing a bend between the two helices. Two
β-strands of C-terminal domain (β9 and β10) are con-
nected by a loop whose length varied among different
RIPs.
The crystals of luffaculin 1 contain two enzyme molecules
(A and B) in the asymmetric unit. A comparison of mole-
cules A and B shows that the overall structures of these
two molecules are almost identical (Fig. 2) with rmsd of
0.181 Å for 221 Cα atoms. Some deviation between two
molecules occurs at the terminal of the α9-helix that is
involved in the crystal packing.
The electron density of luffaculin 1 clearly indicated the
existence of two well-defined N-acetylglucosamines
(NAGs), each covalently linked to an Asn residue at posi-
tions 77 and 84, respectively. Both N-acetylglucomamines
protrude from the molecular surface and do not have
extensive interaction with the protein. These saccharide
moieties of luffaculin 1 are also distant from the active site
(Fig. 1), suggesting that these saccharide moieties may not
involve in the enzymatic activity. The glycosylation in pro-
tein has been recognized to play important roles in vari-
ous functions, including protein folding in the
endoplasmic reticulum, transport and secretion, anchor-
ing of proteins to target sites, protection from protease,
and increased protein conformational stability [31,32].
Table 1: Data collection and model refinement statistics for luffaculin 1
Space group P1
Cell parameters a = 39.135 Å, b = 46.813 Å, c = 83.571 Å, α = 89.068°, β = 80.009°, γ = 72.143°
Resolutions (Å) 1.4
Completeness (%) 86.7 (62.0)
Redundancy 1.9 (1.7)
Rmerge (%)a 0.03 (0.115)
Unique reflections 94795
I/σ(I) 21.8 (4.6)
Resolution range 50.00-1.40 (1.45-1.40)
Rwork 0.213 (0.250)
Rfree 0.232 (0.275)
No. of water molecules 492
No. of carbohydrates 4 per asymmetric unit
No. of polyethylene glycols 3
R.m.s.deviations from ideal geometry
Bond lengths (Å) 0.007
Bond angles (°) 1.153
Values in parentheses refer to the highest resolution shell (1.45-1.40) Å.
a Rmerge = Σ|Ii-<I>|/ΣIi, where Ii is the intensity of the ith observation and <I> is the mean intensity of the reflections.BMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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X-ray sequence of luffaculin 1
The sequence of luffaculin 1 was unknown. Only the first
five residues in N-terminal region were determined to be
DVSFS by N-terminal sequencing. Both luffaculin 1 and
luffin a belong to the same genus (Luffa) but different spe-
cies in the Cucurbitaceae family, thus they are expected to
share high sequence homology. For structural determina-
tion of luffaculin 1, we used luffin a to build a homology
model for molecular replacement method. Although the
sequence of luffaculin 1 is not yet known, the high resolu-
tion of electron density, combined with the known
sequence of homolog luffin a, has allowed us to under-
take an 'X-ray sequencing' method with a high degree of
confidence. For this purpose, we used annealed compos-
ite and σ-weighted 2Fo-Fc omit maps [33] throughout
this work to reduce model bias. The electron density
allowed us to identify differences between luffaculin 1
and its molecular replacement model, luffin a. For exam-
ple, residues 3 and 64 were reported as Arg and Val in luf-
fin a, whereas in luffaculin 1 these residues were
recognized unambiguously as Ser and Ile, respectively
(Fig. 3a).
Fig. 4 shows the final X-ray sequence of luffaculin 1, its
alignment with other RIPs, the correlation coefficient
(real space fit [34]) between the electron density and the
assigned sequence, and the evaluation of chemical envi-
ronments (hydrophobic interactions, hydrogen bonds
and salt bridges) of the residues that cannot be distin-
guished by electron density (i.e. Asp/Asn, Glu/Gln, and
Val/Thr pairs). The reliability of this X-ray sequence
assignment is summarized in Table 2.
Based on the electron density, majority of the residues can
be assigned unambiguously. Some examples are illus-
Overall structure of luffaculin 1 in stereo representation Figure 1
Overall structure of luffaculin 1 in stereo representa-
tion. The two domains at the N- and C-terminal were 
colored in cyan and violet, respectively. Stick representations 
are residues Tyr70, Tyr110, Glu159 and Arg162 in the active 
site, and the two N-acetylglucosamines that are each cova-
lently linked to Asn 77 and 84, respectively. All figures except 
for Fig. 4 were prepared using Pymol [46].
Table 2: Assignment of the sequence of luffaculin 1 by X-ray sequencing method (total number of residues: 241)
Sequence assignment method Number of identified residues
1 Both molecule A and B have clear electron density and can be assigned 
unambiguously
151
2 Using method 1 plus electron density of the second molecule for 
those residues where the first molecule has weak electron density, 
66% of residues (160) can be deduced
160 (9 additional residues were assigned: A123, A185, A206, A215, 
A219, A221, A222, A234 and B209)
3 Using methods 1 and 2 plus chemical environment evaluation without 
using sequence comparison, 86% of residues (208) can be deduced.
208 (exclude 28*, 29, 33*, 48*, 56*, 93*, 97, 109*, 111*, 122*, 132*, 
142*, 156*, 157*, 169*, 177*,179, 190*, 197*, 202*, 204*, 205*, 213*, 
216*, 217, 218, 220*, 223*, 225, 226*, 228, 237*, 241*)
4 Using method 3 plus the sequence comparison, 94% of residues (227) 
can be deduced.
227 (exclude 28*, 29, 97, 109**, 111**, 190*, 216*, 217, 218, 220*, 
225, 228, 223*, 237*)
Neither molecule A nor B has clear density map, but the sequence is 
highly conserved among RIPs
4 (A&B109*, A&B179, A&B111*, A&B223*)
Neither molecule A nor B has clear density map, and the sequence is 
not conserved among RIPs
6 (A&B29, A&B97, A&B217, A&B218, A&B225, A&B228)
*These residues belong to residue pairs (Asn/Asp, Gln/Glu, Val/Thr) and cannot be distinguished by X-ray crystallography.
**These two residues are conserved, but the electron density of both molecules A and B isn't clear, so we cannot classify these two residues to 
Group 4.BMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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trated in Fig. 3b for residues 46, 94 and 129. The two pro-
tein molecules (A and B) in the crystal should have the
identical amino-acid sequence. This redundancy provides
an additional level of validation on the electron-density-
based sequence assignment (Fig. 3a and 3b). In the case
that electron density is disordered or weak in one mole-
cule, the electron density of the other molecule allows the
identification of the sequence (9 residues are in such case,
see Table 2 and Fig. 3c). Fig. 3c shows an example where
residue 185 has weak electron density in molecule B but
can be clearly identified as Ile in molecule A. 66% of resi-
dues (160 out of a total of 241 residues, see Table 2) of luf-
faculin 1 can be identified with confidence purely based
on the high resolution electron density. Similar to our
results, a previous study [4] suggested that 60% of resi-
dues can be identified reliably based on electron density.
An inherent problem of X-ray sequencing is that some res-
idue pairs (Glu/Gln, Asp/Asn, and Val/Thr) can not be dis-
tinguished completely based purely on electron density.
This is due to the facts that the numbers of electrons in
outer shell of carbon, nitrogen, and oxygen are not too
much different, and thus cannot be distinguished by X-ray
diffraction of protein crystals at a resolution that is usually
far less than atomic resolution. In order to solve this prob-
lem, we used the information of 1) chemical environment
evaluation of amino-acids (hydrophobic interactions,
hydrogen bonds and salt bridges); 2) sequence compari-
son with other RIPs. Information of the glycosylation on
Asn residues also facilitates to break down Asp/Asn ambi-
guity as were the cases for residues Asn77 and Asn84,
where carbohydrate moieties were clearly identified from
the electron density. Fig. 5a shows that Asp65A has a
chemical environment perfect for an Asp, but less possible
for an Asn because only an Asp, but not an Asn, can form
salt bridge with Arg46. Moreover, Asp65 is quite con-
served (Fig. 4) among all RIPs. Four additional residue
pairs (Asp87, Glu159, Glu167 and Glu188) were found to
form salt bridges with other residues, leading to their con-
vincing assignment. Inspection of hydrophobic environ-
ment can also assist to break down Val/Thr ambiguity. Fig.
5b shows an example where the electron density votes for
either a Val or a Thr, but the perfect hydrophobic environ-
ment makes it less possible for a Thr at this position. This
evaluation of chemical environment of residues has
increased the assigned residues from 160 (66%) to 208
(86%, see Table 2). It is not surprising that there are still a
few residues (marked by asterisks in Table 2) that cannot
be distinguished based on their chemical environment.
Fig. 5c shows that Gln220 of molecule A has no interac-
tion with any other residues except for a hydrogen bond
with a water molecule (S327). The Gln220 in the mole-
cule B is not observed in the electron density, so we can-
not conclude A220 as a Glu or Gln. It was reported [3] that
the side chain of Ser can distribute among two conforma-
tions and may thus look like a Thr residue, albeit at
weaker electron density. In our case, no such ambiguity
was found.
Four residues (109, 111, 179 and 223) have weak electron
density in both molecule A and molecule B (Table 2), and
thus cannot be assigned based on electron density. All
these four residues are located either at loop region or at
the surface of the molecules. However, these four residues
are highly conserved among various RIPs (Fig. 4), and are
thus tentatively assigned according to the sequences of
their homologous proteins. Residues (29, 97, 217, 218,
225 and 228) do not have enough electron density of side
chains in both molecules and are not conserved in RIP
sequences, and thus cannot be assigned in this study. They
are currently tentatively assigned as Ala or Gly.
In summary, the evaluation of chemical environment
greatly facilitates to break down the ambiguity (Table 2):
32 out of a total of 36 Val/Thr pairs and 16 out of a total
of 38 Asp/Asn and Glu/Gln pairs were assigned by this
method. By using electron density and evaluation of
chemical environment, 86% of residues were assigned
with confidence. Assignment based on sequence compar-
ison, although not absolutely reliable, further increases
the number of the identified residues to 227 (94% of a
total of 241 residues).
X-ray sequencing method has been successfully used to
determine the amino-acid sequence of PAP-Saci  [3], a
Pokeweed antiviral protein, and trichomaglin [4]. The
Superposition of molecule A (cyan) and B (magenta) of luffac- ulin 1 Figure 2
Superposition of molecule A (cyan) and B (magenta) 
of luffaculin 1. The slight deviation is indicated in a dashed 
circle. Residues not present in the molecule B are outlined in 
the boxes.BMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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sequence of PAP-Saci was obtained from the exceptional
quality of the electron density at 1.7 Å resolution, com-
bined with the known sequence of the two PAP-S iso-
forms. The authors claimed that almost all amino-acid
side chains were identified with a high degree of certainty
(with the exception of Asp/Asn and Glu/Gln ambiguities).
The X-ray sequence of trichomaglin was obtained by com-
bining those derived from electron density at 2.2 Å resolu-
tion with the partial sequence information from mass
spectroscopic analysis and the experimentally determined
N-terminal sequence. 60% of the X-ray sequence was thus
demonstrated to be highly reliable. In this paper we got
the X-ray sequence of luffaculin 1 based on the high reso-
lution (1.4 Å) electron density, cross-validated by the sec-
ond molecule in the asymmetric unit of the crystals, and
combined with the evaluation of the chemical environ-
ment of selected residues.
Comparison with other RIPs and the active site
Fig. 4 shows the structure-based alignment of luffaculin 1
with selected type 1 RIPs, including luffaculin 1, luffin a,
luffin b, α-momorcharin, trichosanthin and bryodin. The
amino-acid sequence of luffaculin 1 shows high degree of
sequence identities to other RIPs: 94% for luffin a, 83%
for luffin b, 73% for α-momorcharin, 64% for bryodin,
and 63% for trichosanthin, respectively. The active site is
the most conserved region at both sequence and structure
level as observed. This indicates that the function and the
enzymatic mechanisms of luffaculin 1 are probably the
same as other RIPs [35].
The active site is located in a cleft between the N-terminal
domain and the C-terminal domain, which serves as the
substrate-binding and catalysis site in RIPs (Fig. 1). Fig. 6
shows the conformations of luffaculin 1 catalytic residues,
superimposed with those of other RIPs. The side chains of
the active site residues have roughly the same position as
the corresponding residues of other RIPs' structures
[15,36], whereas Tyr70 shows relatively higher mobility
in all analyzed RIPs. It has been reported that this residue
interacts with the targeted adenine [37], and together with
a second tyrosine (Tyr110 in luffaculin 1), forms an aro-
matic stack of π electron system. The conformational flex-
ibility of Tyr70 side chain may promote the substrate
recognition and the formation of the aromatic stack.
The final model of luffaculin 1 shows a common "RIP
fold". The superposition of Cα atoms of luffaculin 1 to tri-
chosanthin, α-momorcharin and β-luffin gave rmsd (root
mean square deviation) values of 0.527, 0.492 and 0.359
Å, respectively. Despite this overall structural similarity of
luffaculin 1 to other RIPs (Fig. 7), some noticeable differ-
ences exist in surface exposed loop regions particularly
those between β3-strand and α2-helix, and between α8-
The presence of two molecules in the asymmetric unit facilitates sequence identification Figure 3
The presence of two molecules in the asymmetric unit facilitates sequence identification. (a) shows residues 3 
and 64 in molecule A and B of luffaculin 1 contoured at 2σ and these residues are different from luffin a. (b) shows residues 46, 
94 and 129 with clear electron density in molecule A and B contoured at 2σ. (c) shows residue 185 with weak electron density 
in molecule B can be clearly recognized as Ile in the electron density of molecule A.BMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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X-ray sequence of luffaculin 1 and multiple sequence alignments Figure 4
X-ray sequence of luffaculin 1 and multiple sequence alignments. These alignments are of luffaculin 1 (LF1), luffin a 
(LUA), luffin b (LUB), α-momorcharin (MOM), trichosanthin (TCS) and bryodin (BRY). Highlighted residues are the active site 
residues. Panel Seq Ident indicates the sequence homology calculated by program clustalx 1.83. Panel CC_A and CC_B are the 
real space fit (RS fit, calculated by program O ranging from 0 to 1) of the residues between current luffaculin 1 and composite 
omit map of luffaculin 1. Panel Env represents the evaluation of chemical environment on residue pairs (Glu/Gln, Asp/Asn, Val/
Thr) that cannot be distinguished by X-ray crystallography. H/L stands for high/low confidence in breaking down this ambiguity 
based on its chemical environment (hydrophobic interactions, hydrogen bonds and salt bridges).
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and α9-helix. The largest deviation occurs at the β8-strand
of the N-terminal region (box C in Fig. 7).
Conclusion
We present the 1.4 Å resolution crystal structure of luffac-
ulin 1 and its X-ray sequence. This sequence was derived
based on the high resolution electron density, validated
against the second molecule present in the crystals, the
evaluation of the chemical environment of selected resi-
dues, and the sequence comparison with other homo-
logues. A total of 86% (without using sequence
comparison) or 94% (with sequence comparison) of luf-
faculin 1 residues can be assigned with confidence by this
approach. The luffaculin 1 is quite similar to luffin a at
both sequence and structural levels, suggesting its func-
tions as an RIP.
Methods
Purification and crystallization
Luffaculin 1 was extracted and purified by extraction with
acetate buffer, ammonium sulfate fractional precipitation
and cation exchange chromatography [25]. It was eluted
as a single symmetrical peak in a cation exchange column
(Mono S, Amersham Pharmacia Biotech) and gave a sin-
gle band with an apparent molecular weight of about 28
kDa by reducing SDS-PAGE. The purified luffaculin 1 was
thoroughly dialyzed against deionized water and lyophi-
lized. For crystallization, lyophilized powder of luffaculin
1 was dissolved to a concentration of 15.8 mg/mL and
then crystallized by hanging drop vapor diffusion method
[38] at room temperature by mixing 2 μL protein (15.8
mg/mL) with an equal volume of reservoir solution (28%
(w/v) PEG 6000, 0.1 M citrate buffer pH4.5, containing
0.02% (w/v) sodium azide) and equilibrating against 800
μL of the same reservoir solution. The crystal was briefly
dipped into a cryoprotectant, 20% of glycerol (final con-
centration) in the reservoir solution, before data collec-
tion.
Data collection and processing
Diffraction data of the crystals were collected using syn-
chrotron radiation (APS SER-CAT beamline 22ID) at low
temperature (100K) to improve the diffraction quality
and to decrease the radiation decay. A 1.4 Å resolution
data set was obtained and the diffraction data were proc-
essed with the program package HKL2000 [39]. The crys-
tals belong to space group P1, with unit-cell parameters a
= 39.135 Å, b = 46.813 Å, c = 83.571 Å, α = 89.068°, β =
80.009°, γ = 72.143°. Matthews coefficient calculations
[40] show two molecules present in the asymmetric unit
Structural superposition of the active site residues Figure 6
Structural superposition of the active site residues. 
Trichosanthin, α-momorcharin, β-luffin and luffaculin 1 are 
colored as green, cyan, magenta and yellow, respectively.
The electron density of Asp65, Val212 and Gln220 of molecule A Figure 5
The electron density of Asp65, Val212 and Gln220 of molecule A. This map (2Fo-Fc composite omit map) is con-
toured at 1σ. Hydrogen bonds are denoted by dashed lines with numbers denoting the respective distances in the unit of Å. (a) 
shows that Asp65 of molecule A has hydrogen bond interaction with Thr67 and salt bridge with Arg46 besides interaction with 
water molecules S244 and S265. (b) shows that Val212 of molecule A resides in a hydrophobic environment. (c) shows that 
Gln220 of molecule A has no interaction with other residues except the hydrogen bond with the symmetry related water mol-
ecule S327.BMC Structural Biology 2007, 7:29 http://www.biomedcentral.com/1472-6807/7/29
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and the value of Vm is 2.49 Å Da-1 corresponding to a sol-
vent content of 48%. The statistics for the data set are sum-
marized in Table 1. The final merged data set of 94795
unique reflections has high quality with an Rmerge of
0.03 and an averaged signal to noise ratio of 21.8.
Structure determination and model refinement
The structure of luffaculin 1 was solved by the molecular
replacement method (AMORE [41,42]) using a homology
model built based on the sequence of luffin a [43,44]. Luf-
fin a and luffaculin 1 were both purified from the same
genus but different species in the Cucurbitaceae family,
and were expected to share high sequence homology and
structure similarity. Rotational solutions in the resolution
range of 8-4 Å showed two clear peaks with the high cor-
relation coefficients of 0.223 and 0.199, respectively, and
the corresponding third highest value was 0.071. Then,
the translation vector of the first solution was fixed
because of the space group P1 of luffaculin 1 and the
translation search was performed for the second solution,
giving a higher correlation coefficient of 0.429. The refine-
ment was performed with the program CNS [33] in a res-
olution range from 50-1.4 Å. A total of 5% of the data was
randomly selected for Rfree calculation throughout the
whole refinement. After a starting cycle of rigid body
refinement, the R factor was 0.3360 and Rfree was 0.3518.
Simulated annealing and restrained individual B-factor
refinement were then performed. The sigma A weighted
2Fo-Fc and Fo-Fc electron density maps were used to
guide the model building process. The model was exam-
ined and manually rebuilt with the graphic program O
[34]. In the final stage of the refinement, water molecules
were added by CNS at locations where electron density
was stronger than 3.0σ in sigma A-weighted Fo-Fc maps
and had reasonable hydrogen-bond interaction with the
protein, and then were inspected with program O. The
carbohydrates and the polyethylene glycol (PEG) mole-
cules [see Additional file 1] were visible at this stage in
2Fo-Fc and Fo-Fc electron density maps and were built in.
Luffaculin 1 was crystallized from the solution containing
PEG6000. It is inevitable that there are some low molecu-
lar weight polyethylene glycol molecules existed in the
PEG6000 and these small molecules most likely penetrate
into crystals. Such cases can also be found in the PDB data
bank, for example, in PDB entry 2FD6 [45]. The final
model has R factor and Rfree of 0.213 and 0.232, respec-
tively, containing 492 water molecules, one PEG1 (tetrae-
thylene glycol), two PEG2 (diethylene glycol) and four N-
acetylglucosamines (NAG) in the asymmetric unit. Data
collection and model refinement statistics are listed in
Table 1.
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Superposition of Cα atoms of trichosanthin (green), α- momorcharin (cyan), β-luffin (magenta) and luffaculin 1 (yel- low) Figure 7
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Page 10 of 10
(page number not for citation purposes)
USA are gratefully acknowledged. Use of the Advanced Photon Source was 
supported by the US Department of Energy, Office of Science, Office of 
Basic Energy Sciences, under contract No.W-31-109-Eng-38. We thank 
Yujun Wang of University of Alabamaba in Huntsville as well as the staffs of 
the APS SER-CAT beamline 22ID for help with data collection. The coor-
dinates of luffaculin 1 have been deposited in PDB (code 2OQA).
References
1. Liang SP: Techniques of protein sequencing at the turn of the
centuries.  Chinese Bulletin of Life Sciences 1999, 11(1):31-35.
2. Chambery A, de Donato A, Bolognesi A, Polito L, Stirpe F, Parente A:
Sequence determination of lychnin, a type 1 ribosome-inac-
tivating protein from Lychnis chalcedonica seeds.  Biological
chemistry 2006, 387(9):1261-1266.
3. Hogg T, Kuta Smatanova I, Bezouska K, Ulbrich N, Hilgenfeld R:
Sugar-mediated lattice contacts in crystals of a plant glyco-
protein.  Acta Crystallogr D Biol Crystallogr 2002, 58(Pt 10 Pt
1):1734-1739.
4. Gan JH, Yu L, Wu J, Xu H, Choudhary JS, Blackstock WP, Liu WY,
Xia ZX: The three-dimensional structure and X-ray sequence
reveal that trichomaglin is a novel S-like ribonuclease.  Struc-
ture 2004, 12(6):1015-1025.
5. Barbieri L, Battelli MG, Stirpe F: Ribosome-inactivating proteins
from plants.  Biochim Biophys Acta 1993, 1154(3-4):237-282.
6. Stirpe F, Barbieri L: Ribosome-inactivating proteins up to date.
FEBS Lett 1986, 195(1-2):1-8.
7. Damme EJMV, Hao Q, Chen Y, Barre A, Vandenbussche F, Desmyter
S, Rougé P, Peumans WJ: Ribosome-Inactivating Proteins: A
Family of Plant Proteins That Do More Than Inactivate
Ribosomes.  Critical Reviews in Plant Sciences 2001, 20(5):395-465.
8. Pan KZ, Lin YJ, Zhou KJ, Fu ZJ, Chen MH, Huang DR, Huang DH: The
crystal and molecular structure of trichosanthin at 2.6 A res-
olution.  Sci China B 1993, 36(9):1069-1081.
9. Stirpe F, Barbieri L, Battelli MG, Falasca AI, Abbondanza A, Lorenzoni
E, Stevens WA: Bryodin, a ribosome-inactivating protein from
the roots of Bryonia dioica L. (white bryony).  Biochem J 1986,
240(3):659-665.
10. Husain J, Tickle IJ, Wood SP: Crystal structure of momordin, a
type I ribosome inactivating protein from the seeds of
Momordica charantia.  FEBS Lett 1994, 342(2):154-158.
11. Yuan YR, He YN, Xiong JP, Xia ZX: Three-dimensional structure
of beta-momorcharin at 2.55 A resolution.  Acta Crystallogr D
Biol Crystallogr 1999, 55 (Pt 6):1144-1151.
12. Masahiro K, Hiromi N, Gunki F: Isolation and Characterization
of Two Luffins, Protein-biosynthesis Inhibitory Proteins
from the seeds of Luffa cylindrica.  Agric Biol Chem 1988,
52(5):1223-1227.
13. Chen MH, Ye XM, Cai JH, Lin YJ: Crystallization and preliminary
crystallographic study of cucurmosin, a ribosome-inactivat-
ing protein from the sarcocarp of Cucurbita moschata.  Acta
Crystallogr D Biol Crystallogr 2000, 56 (Pt 5):665-666.
14. Rutenber E, Katzin BJ, Ernst S, Collins EJ, Mlsna D, Ready MP, Rober-
tus JD: Crystallographic refinement of ricin to 2.5 A.  Proteins
1991, 10(3):240-250.
15. Tahirov TH, Lu TH, Liaw YC, Chen YL, Lin JY: Crystal structure of
abrin-a at 2.14 A.  J Mol Biol 1995, 250(3):354-367.
16. Chaudhry B, Muller-Uri F, Cameron-Mills V, Gough S, Simpson D,
Skriver K, Mundy J: The barley 60 kDa jasmonate-induced pro-
tein (JIP60) is a novel ribosome-inactivating protein.  Plant J
1994, 6(6):815-824.
17. Jin YC: Intra-amniotic injection of crystal trichosanthin for
induction of labour in second trimester pregnancy.  Shengzhi
Yu Biyun 1985, 5(1):15-17, 20.
18. Leah R, Tommerup H, Svendsen I, Mundy J: Biochemical and
molecular characterization of three barley seed proteins
with antifungal properties.  J Biol Chem 1991, 266(3):1564-1573.
19. Bolognesi A, Polito L: Immunotoxins and other conjugates: pre-
clinical studies.  Mini Rev Med Chem 2004, 4(5):563-583.
20. Pastan II, Kreitman RJ: Immunotoxins for targeted cancer ther-
apy.  Adv Drug Deliv Rev 1998, 31(1-2):53-88.
21. Au TK, Collins RA, Lam TL, Ng TB, Fong WP, Wan DC: The plant
ribosome inactivating proteins luffin and saporin are potent
inhibitors of HIV-1 integrase.  FEBS Lett 2000, 471(2-3):169-172.
22. Wang JH, Nie HL, Tam SC, Huang H, Zheng YT: Anti-HIV-1 prop-
erty of trichosanthin correlates with its ribosome inactivat-
ing activity.  FEBS Lett 2002, 531(2):295-298.
23. Parikh BA, Tumer NE: Antiviral activity of ribosome inactivat-
ing proteins in medicine.  Mini Rev Med Chem 2004, 4(5):523-543.
24. Wang P, Tumer NE: Virus resistance mediated by ribosome
inactivating proteins.  Adv Virus Res 2000, 55:325-355.
25. Lin JK, Chen MH, Xie JM, Zhao R, Ye XM, Shi XL, Wang ZR: Purifi-
cation and Characterization of Two Luffaculins, Ribosome-
inactivating Proteins from Seeds of Luffa acutangula.  Chinese
Journal of Biochemistry and Molecular Biology 2002, 18(5):609-613.
26. Chen MH, Shi XL, Ye XM, Xie JM, Zhao R, Rao PF, Wang ZR: Study
on the secondary structure and bioactivities of Luffaculin 1.
Chinese J Struct Chem 2004, 23:232-235.
27. Zhao R, Xie JM, Xu JH, Chen MH, Lin JK, Ye XM: Apoptosis-induc-
ing effect of luffaculin on K562 cells.  Pharmacology and Clinics of
Chinese Materia Medica 2001, 17(6):24-26.
28. XIE JM, Chen MH, Xu Y, Zhao R, Xu JH, Yu ZX: Differentiation-
inducing effect of Luffaculin-1 on B16 melanoma cells.  Chin J
Cancer Prev Treat 2005, 12(20):1521-1524.
29. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton
JM: AQUA and PROCHECK-NMR: programs for checking
the quality of protein structures solved by NMR.  J Biomol NMR
1996, 8(4):477-486.
30. Savino C, Federici L, Ippoliti R, Lendaro E, Tsernoglou D: The crys-
tal structure of saporin SO6 from Saponaria officinalis and
its interaction with the ribosome.  FEBS Lett 2000,
470(3):239-243.
31. Rudd PM, Wormald MR, Stanfield RL, Huang M, Mattsson N, Speir JA,
DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA: Roles for glyco-
sylation of cell surface receptors involved in cellular immune
recognition.  J Mol Biol 1999, 293(2):351-366.
32. Wormald MR, Dwek RA: Glycoproteins: glycan presentation
and protein-fold stability.  Structure 1999, 7(7):R155-60.
33. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-
Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ,
Rice LM, Simonson T, Warren GL: Crystallography & NMR sys-
tem: A new software suite for macromolecular structure
determination.  Acta crystallographica 1998, 54(Pt 5):905-921.
34. Jones TA, Zou JY, Cowan SW, Kjeldgaard M: Improved methods
for building models in electron density maps and the location
of errors in these models.  Acta Crystallogr A 1991, 47:110-119.
35. Monzingo AF, Robertus JD: X-ray analysis of substrate analogs
in the ricin A-chain active site.  J Mol Biol 1992,
227(4):1136-1145.
36. Fermani S, Falini G, Ripamonti A, Polito L, Stirpe F, Bolognesi A: The
1.4 anstroms structure of dianthin 30 indicates a role of sur-
face potential at the active site of type 1 ribosome inactivat-
ing proteins.  Journal of structural biology 2005, 149(2):204-212.
37. Robertus JD, Monzingo AF: The structure of ribosome inactivat-
ing proteins.  Mini Rev Med Chem 2004, 4(5):477-486.
38. Mcpherson A: Preparation and Analysis of Protein Crystals.
New York , John Wiley; 1982:82-159. 
39. Otwinnowski Z, Minor W: Processing of X-ray diffraction data
collected in oscillation model.  Methods Enzymol 1997,
276:307-326.
40. Matthews BW: Solvent content of protein crystals.  J Mol Biol
1968, 33(2):491-497.
41. Navaza J: AmoRe-an automated package for molecular
replacement.  Acta Crystallogr A 1994, 50:157-163.
42. Navaza J: Implementation of molecular replacement in
AMoRe.  Acta Crystallogr D Biol Crystallogr 2001, 57(Pt
10):1367-1372.
43. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-Pdb-
Viewer: an environment for comparative protein modeling.
Electrophoresis 1997, 18(15):2714-2723.
44. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An
automated protein homology-modeling server.  Nucleic Acids
Res 2003, 31(13):3381-3385.
45. Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J, Li Y, Yuan
C, Bian C, Chen L, Furie B, Furie BC, Cines DB, Huang M: Structure
of human urokinase plasminogen activator in complex with
its receptor.  Science (New York, NY 2006, 311(5761):656-659.
46. DeLano WL: The PyMOL Molecular Graphics System.  2002
[http://www.pymol.org].